Platform
A connected platform for IBD monitoring between visits
IBDi brings together patient-reported data, home fecal calprotectin testing, and clinician-reviewed monitoring in one structured workflow.
System architecture
Three components, one workflow
Patient app
Symptoms, medication, quality of life
Calpro Smart
Home fecal calprotectin
Structured data
Longitudinal record
Clinical review
Clinician-reviewed monitoring
Patient app
Structured reporting from home
The IBDi patient app helps participants complete structured reporting from home. Current functions include symptom reporting, medication logging and reminders, quality-of-life reporting, patient experience questions, and home fecal calprotectin workflow support.
Symptoms
Structured symptom reporting on a regular cadence.
Medication
Medication logging and reminders.
Quality of life
Validated patient-reported quality-of-life questions.
Home testing
Guided home fecal calprotectin workflow.
Clinical review
A structured view for clinical teams
The IBDi clinical review interface gives clinical teams a structured view of patient-reported information over time. It supports patient overview, status tracking, notifications, progress views, graphs, comments, and follow-up documentation inside a clinician-reviewed workflow.
Patient overview
One place for status, recent activity, and history.
Notifications
Surface relevant changes for clinician review.
Graphs and comments
Longitudinal views with clinician notes and follow-up.
Home calprotectin
A biomarker that fits the monitoring loop
Fecal calprotectin is an important biomarker in IBD monitoring. IBDi integrates a home-testing workflow through Calpro Smart DeepLink, allowing calprotectin results to become part of the structured remote-monitoring process.
IBDi supports home fecal calprotectin reporting as part of clinician-reviewed monitoring.
Monitoring loop
From enrolment to follow-up
Clinic enrols patient
Activation code
Patient reports + tests
Clinical review
Clinician follow-up
Current scope
What the platform does and does not do today
The platform does
Collect structured patient-reported data, support home fecal calprotectin reporting, and surface information for clinician review and follow-up.
The platform does not
Provide autonomous diagnosis, prediction, or treatment recommendations. The current version is not CE marked.
The current IBDi version is being used in live clinical studies. It supports structured reporting and monitoring workflows but is not CE marked and is not intended to provide autonomous diagnosis, prediction, or treatment recommendations.
Want to learn more?
Read where the platform is heading, or get in touch about collaboration and implementation.